Diverse effects of LPA receptors on cell motile activities of cancer cells

References

• Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 2003;3:582–91
   PubMed Web of Science ®Google Scholar
• Ishii I, Fukushima N, Ye X, et al. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem 2004;73:321–54
   PubMed Web of Science ®Google Scholar
• Ishii S, Noguchi K, Yanagida K. Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat 2009;89:57–65
   Google Scholar
• Choi JW, Herr DR, Noguchi K, et al. LPA receptors: subtypes and biological actions. Anu Rev Pharmacol Toxicol 2010;50:157–86
   PubMed Web of Science ®Google Scholar
• Xu Y, Gaudette DC, Boynton JD, et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res 1995;1:1223–32
   PubMed Web of Science ®Google Scholar
• Watanabe N, Ikeda H, Nakamura K, et al. Both plasma lysophosphatidic acid and serum autotoxin levels are increased in chronic hepatitis C. J Clin Gastroenterol 2007;41:616–23
   PubMed Web of Science ®Google Scholar
• Tager AM, LaCamera P, Shea BS, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 2008;14:45–54
   PubMed Web of Science ®Google Scholar
• Lin M-E, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 2010;91:130–8
   PubMed Web of Science ®Google Scholar
• Tsujiuchi T, Okabe K, Fukushima N. Genetic and epigenetic alterations of lysophosphatidic acid receptor genes in rodent tumors by experimental models. J Toxicol Pathol 2011;24:143–8
   Google Scholar
• Yamada T, Furukawa M, Hotta M, et al. Mutations of lysophosphatidic acid receptor-1 gene during progression of lung tumors in rats. Biochem Biophys Res Commun 2009;378:424–7
   PubMed Web of Science ®Google Scholar
• Obo Y, Yamada T, Furukawa M, et al. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors. Mutat Res 2009;660:47–50
   PubMed Web of Science ®Google Scholar
• Okabe K, Hayashi M, Fujii M, et al. Mutations of lysophosphatidic acid receptor genes in human osteosarcoma cells. Pathobiology 2010;77:278–82
   PubMedGoogle Scholar
• Wakabayashi N, Tsujino M, Tajiri M, et al. No mutations of lysophosphatidic acid receptor genes in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats. J Toxicol Pathol 2010;23:63–6
   Google Scholar
• Schulte KM, Beyer A, Köhrer K, et al. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer. Int J Cancer 2001;92:249–56
   PubMed Web of Science ®Google Scholar
• Shida D, Watanabe T, Aoki J, et al. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Invest 2004;84:1352–62
   PubMedGoogle Scholar
• Kitayama J, Shida D, Sako A, et al. Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma. Breast Cancer Res 2004;6:R640–6
   PubMed Web of Science ®Google Scholar
• Tsujino M, Fujii M, Okabe K, et al. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells. Virchows Arch 2010;457:669–76
   PubMed Web of Science ®Google Scholar
• Okabe K, Hayashi M, Wakabayashi N, et al. Different expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in mouse tumor cells. Pathobiology 2010;77:309–14
   PubMedGoogle Scholar
• Ridley AJ, Schwartz MA, Burridge K, et al. Cell migaration: integrating signals from front to back. Science 2003;302:1704–9
   PubMed Web of Science ®Google Scholar
• Aoki J, Inoue A, Okudaira S. Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 2008;1781:513–18
   PubMed Web of Science ®Google Scholar
• Choi JW, Chun J. Lysophospholipids and their receptors in the central nervous system. Biochim Biophys Acta 2013;1831:20–32
   Web of Science ®Google Scholar
• Eichholtz T, Jalink K, farenfort I, et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 1993;291:677–80
   PubMed Web of Science ®Google Scholar
• Tabata K, Baba K, Shiraishi A, et al. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun 2007;363:861–6
   PubMedGoogle Scholar
• Wells A, Grahovac J, Wheeler S, et al. Targeting tumor cell motility as a strategy against invasion and metastasis. Trends Pharmacol Sci 2013;34:283–9
   PubMed Web of Science ®Google Scholar
• Sahai E. Illuminating the metastatic process. Nat Rev Cancer 2007;7:737–49
   PubMed Web of Science ®Google Scholar
• Shida D, Kitayama J, Yamaguchi H, et al. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 2003;63:1706–11
   PubMed Web of Science ®Google Scholar
• Shida D, Kitayama J, Yamaguchi H, et al. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells. Exp Cell Res 2004;301:268–78
   Google Scholar
• Hayashi M, Okabe K, Kato K, et al. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett 2012;316:91–6
   PubMed Web of Science ®Google Scholar
• Okabe K, Hayashi M, Kato K, et al. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells. Mol Carcinog 2013;52:247–54
   Google Scholar
• Tanabe E, Kitayoshi M, Yoshikawa K, et al. Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells. J Recept Signal Transduct Res 2012;32:328–34
   PubMed Web of Science ®Google Scholar
• Hayashi M, Okabe K, Yamawaki Y, et al. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Biochem Biophys Res Commun 2011;405:450–4
   PubMedGoogle Scholar
• Okabe K, Hayashi M, Yamawaki Y, et al. Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells. Mol Carcinog 2011;50:635–42
   Google Scholar
• Yu S, Murph MM, Lu Y, et al. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Cancer Inst 2008;100:1630–42
   PubMed Web of Science ®Google Scholar
• Kato K, Yoshikawa K, Tanabe E, et al. Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells. Tumor Biol 2012;33:1739–44
   Google Scholar
• Fukui R, Tanabe E, Kitayoshi M, et al. Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells. Tumor Biol 2012;33:1899–905
   Google Scholar
• Chen P, Parks WC. Role of matrix metalloproteinases in epithelial migration. J Cell Biochem 2009;108:1233–43
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010;141:52–67
   PubMed Web of Science ®Google Scholar
• Fishman DA, Liu Y, Ellerbrock SM, et al. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res 2001;61:3194–9
   PubMed Web of Science ®Google Scholar
• Jeong KJ, Park SY, Cho KH, et al. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. Oncogene 2012;31:4279–89
   Google Scholar
• Park SY, Jeong KJ, Panupinthu N, et al. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene 2011;30:1351–9
   PubMed Web of Science ®Google Scholar
• Kato K, Fukui R, Okabe K, et al. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2. Biochem Biophys Res Commun 2012;417:790–3
   PubMedGoogle Scholar
• Shano S, Hatanaka K, Ninose S, et al. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim Biophys Acta 2008;1783:748–59
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182–6
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669–76
   PubMed Web of Science ®Google Scholar
• Goetzl EJ, Dolezalova H, Kong Y, et al. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res 1999;59:5370–5
   PubMed Web of Science ®Google Scholar
• Hu Y-L, Tee M-K, Goetzl EJ, et al. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst 2001;93:762–8
   PubMed Web of Science ®Google Scholar
• Fujita T, Miyamoto S, Onoyama I, et al. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett 2003;192:161–9
   PubMed Web of Science ®Google Scholar
• Kitayoshi M, Kato K, Tanabe E, et al. Enhancement of endothelial cell migration by constitutively active LPA1-expressing tumor cells. Biochem Biophys Res Commun 2012;422:339–43
   Google Scholar
• Tisty TD, Hein PW. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001;11:54–9
   PubMed Web of Science ®Google Scholar
• Coussens, LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–7
   PubMed Web of Science ®Google Scholar
• Parsonage G, Filer AD, Haworth O, et al. A stromal address code defined by fibroblasts. Trends Immunol 2005;26:150–6
   PubMed Web of Science ®Google Scholar
• Kaiiuri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392–401
   Google Scholar
• Ikeda H, Yatomi Y, Yanase M, et al. Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture. Biochem Biophys Res Commun 1998;248:436–40
   PubMed Web of Science ®Google Scholar
• Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000;35:665–72
   PubMed Web of Science ®Google Scholar
• Yotti LP, Chang CC, Trosko JE. Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 1979;208:1089–91
   Google Scholar
• Enomoto T, Sasaki Y, Shiba Y, et al. Tumor promoters cause a rapid and reversible inhibition of the formation and maintenance of electrical cell coupling in culture. Proc Natl Acad Sci U S A 1981;78:5628–32
   PubMed Web of Science ®Google Scholar
• Lin CW, Shen SC, Chien C, et al. 12-O-Tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCα/ERK/NF-κB-dependent MMP-9 expression. J Cell Physiol 2010;225:472–81
   Google Scholar
• Okabe K, Kato K, Teranishi M, et al. Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells. Cancer Lett 2011;309:236–42
   PubMed Web of Science ®Google Scholar
• Farber E. Ethionine carcinogenesis. Adv Cancer Rev 1963;7:383–474
   PubMed Web of Science ®Google Scholar
• Inoue S, Tanabe E, Shibata A, et al. Ethionine regulates cell motile activity through LPA receptor-3 in liver epithelial WB-F344 cells. Mol Cell Biochem 2013;383:173–7
   Google Scholar
• Okabe K, Hayashi M, Yoshida I, et al. Distinct DNA methylation patterns of lysophosphatidic acid receptor genes during rat hepatocarcinogenesis induced by a choline deficient L-amino acid defined diet. Arch Toxicol 2011;85:1303–10
   Google Scholar
• Giretti MS, Simoncini T. Rapid regulatory actions of sex steroids on cell movement through the actin cytoskeleton. Steroids 2008;73:895–900
   Google Scholar
• Boon WC, Chow JD, Simpson ER. The multiple roles of estrogens and the enzyme aromatase. Prog Brain Res 2010;181:209–32
   PubMed Web of Science ®Google Scholar
• Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000;27:67–73
   PubMedGoogle Scholar
• Coelingh Bennink HJ. Are all estrogens the same? Maturitas 2004;47:269–75
   Google Scholar
• Maier WE, Herman JR. Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals. Regul Toxicol Pharmacol 2001;34:53–61
   Google Scholar
• Tanabe E, Shibata A, Inoue S, et al. Regulation of cell motile activity through the different induction of LPA receptors by estrogens in liver epithelial WB-F344 cells. Biochem Biophys Res Commun 2012;428:105–9
   Google Scholar
• Veal EA, Day AM, Morgan BA. Hydrogen peroxide sensing and signaling. Mol Cell 2007;26:1–14
   PubMed Web of Science ®Google Scholar
• Polytarchou C, Hatziapostolou M, Papadimitriou E. Hydrogen peroxide stimulated proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J Biol Chem 2005;280:40428–35
   PubMed Web of Science ®Google Scholar
• Laurent A, Nicco C, Chéreau C, et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 2005;65:948–56
   PubMed Web of Science ®Google Scholar
• Shibata A, Tanabe E, Inoue S, et al. Hydrogen peroxide stimulates cell motile activity through LPA receptor-3 in liver epithelial WB-F344 cells. Biochem Biophys Res Commun 2013;433:317–21
   Google Scholar
• Hirane M, Araki M, Dong Y, et al. Inhibitory effects of LPA1 on cell motile activities stimulated by hydrogen peroxide and 2,3-dimethoxy-1,4-naphthoquinone in fibroblast 3T3 cells. Biochem Biophys Res Commun 2013;441:47–52
   Google Scholar